Ovid Therapeutics (1OT.MU) Q1 2026 Earnings

18MarConfirmed
Q1 2026
-0.1
-0.05
0
0.05

Details

Expected EPS
-0.10213590880000001
Actual EPS
0.0523416
Surprise EPS
0.15
Surprise Percent
+151.25%

Description

Ovid Therapeutics (1OT.MU) has reported earnings of 0.0523416 per share for Q1 2026.

0 Comments

Share your thoughts